Creative Biolabs-Immuno-oncology

Anti-CD138 (clone IO6Z) SynExpress trc-Cy3-I4-E Modified CD8+ T cells (CAT#: ITS-1224-CR952)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD138 (clone IO6Z). We employs the AAV (trc-Cy3-IL-4-EcoRI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD138
Clone
IO6Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
trc
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
AAV
Transformation Accuracy
0.86
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving